Follow
Heba Mohammed Hesham
Heba Mohammed Hesham
Ain Shams university
Verified email at pharma.asu.edu.eg
Title
Cited by
Cited by
Year
Chimeric HDAC inhibitors: Comprehensive review on the HDAC‐based strategies developed to combat cancer
HM Hesham, DS Lasheen, KAM Abouzid
Medicinal research reviews 38 (6), 2058-2109, 2018
1402018
Design, synthesis, molecular docking study, and biological evaluation of salicylaldimine derivatives as potential histone deacetylases inhibitors (HDACi) and anticancer agents
HM Hesham, DS Lasheen, KAM Abouzid
Archives of Pharmaceutical Sciences Ain Shams University 2 (1), 1-15, 2018
12018
FLT3-PROTACs for combating AML resistance: Analytical overview on chimeric agents developed, challenges, and future perspectives
DAAEE Heba M. Hesham , Eman M.E. Dokla , Eman Z. Elrazaz , Deena S. Lasheen
European Journal of Medicinal chemistry 277, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–3